Jeff Himawan

Insider Reports History

Location
Palo Alto, CA
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeff Himawan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 06 Oct 2023 By Pt Rd Foundation
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 06 Oct 2023 By Trust
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 06 Oct 2023 Direct
Horizon Therapeutics Public Ltd Co Director Restricted Stock Units 0 06 Oct 2023 Direct
Horizon Therapeutics Public Ltd Co Director Stock Option (Right to Buy) 0 06 Oct 2023 Direct

Insider Reports Filed by Jeff Himawan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
HZNP Horizon Therapeutics Public Ltd Co 06 Oct 2023 6 -$10,371,762 4 Director 06 Oct 2023, 18:15
HZNP Horizon Therapeutics Public Ltd Co 26 Sep 2023 2 +$446,073 4 Director 27 Sep 2023, 18:13
HZNP Horizon Therapeutics Public Ltd Co 27 Jul 2023 1 $0 4 Director 28 Jul 2023, 16:27
HZNP Horizon Therapeutics Public Ltd Co 09 May 2023 2 $0 4 Director 11 May 2023, 16:48
HZNP Horizon Therapeutics Public Ltd Co 28 Apr 2023 3 -$208,870 4 Director 02 May 2023, 19:21
HZNP Horizon Therapeutics Public Ltd Co 30 Dec 2022 1 $0 4 Director 04 Jan 2023, 15:09
HZNP Horizon Therapeutics Public Ltd Co 28 Apr 2022 4 -$112,260 4 Director 02 May 2022, 18:01